COVID-19 Anxiety Burdens Rare Disease Community
Most Americans have experienced some level of anxiety about the COVID-19 pandemic. Recent survey results show that anxiety is magnified for people living with a rare disease.
COVID-19 Puts Hope on Hold for Rare Disease Patients
The coronavirus pandemic has disrupted nearly every facet of health care.
Medicare Rule Could Delay Migraine, Movement Disorder Treatment
New efforts to rein in Medicare costs could delay treatment for people who need botulinum toxins for migraine or movement disorders.
How COVID-19 Could Change Clinical Trials
COVID-19 has brought many clinical trials to a near standstill unlike most clinical researchers have seen before.
COVID-19 Ushers in New Normal for Cancer Trials
Cancer doesn’t stop. So what happens when clinical trials for cancer treatments do? The question looms as the coronavirus brings trials across the country to a halt.
Will COVID-19 Boost Clinical Trials Awareness?
This year’s Clinical Trials Awareness Week falls squarely in the midst of the COVID-19 pandemic.
Co-Pay Surprise Looms for Chronic Disease Patients
After months of back-and-forth on the question of co-pay accumulator programs, a new federal rule delivers sobering news to patients.
Will COVID-19 Cripple a Weary Health Care Workforce?
As the COVID-19 pandemic approaches its fourth month in the U.S., health care providers are growing weary.
As Unemployment Rises, so Does Health Care Insecurity
As unemployment rates soar to record highs, patients face new health care access challenges.
Cures 2.0 Takes Off
The novel coronavirus may be propelling Cures 2.0 efforts to the forefront.
